Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Clears Sebacia Microparticles for the Treatment of Mild to Moderate Inflammatory Acne

americanpharmaceuticalreviewSeptember 18, 2018

Tag: FDA , Sebacia , microparticles

PharmaSources Customer Service